Immunopathology of
Cardiomyopathy in the Experimental Chagas Disease
Suppl. I: 257-262
Milena BP Soares, Ricardo
RibeirodosSantos+
Laboratório de
Imunofarmacologia, Centro de Pesquisas Gonçalo Moniz-Fiocruz, Rua Valdemar Falcăo 121,
40295-001 Salvador, BA, Brasil
The mechanisms by which Trypanosoma
cruzi causes cardiomyopathy and induces neuronal destruction are discussed in this
paper. The results suggest that autoimmunity in the chronic phase is the main cause of the
progressive cardiac destruction, and that autoreactivity is restricted to the CD4+
T cell compartment. During the acute phase, the neuronal and cardiac fiber destruction
occurs when ruptured parasite nests release T. cruzi antigens that bind to the cell
surface in the vicinity which become targets for the cellular and humoral immune response
against T. cruzi. The various factors involved in the genesis of autoimmunity in
chronic T. cruzi infection include molecular mimicry, presentation of
self-antigens and imbalance of immune regulation.
Key words: cardiomyopathy -
immunopathology - Chagas disease - Trypanosoma cruzi

Chagas disease is caused by a
protozoan parasite, Trypanosoma cruzi, which is transmitted by reduviid bugs.
Approximately 35 million people are exposed to the risk of infection (Puffer &
Griffith 1967) and the disease is one of the leading causes of death in many countries of
Latin America. The disease is characterized by two major clinical forms: acute and chronic
(Ribeiro dos Santos et al. 1981). The acute phase progresses with parasitemia, and the
parasites spread widely in the host organism, replicating inside macrophages and in a
variety of other host cells with a preference for heart muscle cells. It is characterized
histopathologically by foci of myocytolytic necrosis and an impressive mononuclear
inflammatory infiltrate directly related to tissue parasitism. The resulting inflammatory
destruction is usually of only transitory clinical relevance.
Progression from the acute to
chronic form of Chagas disease coincides with clearance of parasites from bloodstream and
tissues. This period can last up to 20 years, and is called indeterminate phase when no
clinical symptoms or significative histopathological lesions are found. The typical
chronic form affects mainly the heart and occurs in approximately 25% of the cases.
Variable degrees of cardiac hypertrophy and dilatation are found with or without thinning
of the apical region (apical aneurysm). Foci of myocardial necrosis and degeneration are
present with an inflammatory infiltrate predominantly composed of mononuclear cells and
interstitial fibrosis. Importantly, myofibers containing parasites are rarely observed
(Köberle 1968). The other clinical forms consists of the megamorphic dilatations of the
oesophagus and colon, which occur in less than 10% of the infected individuals, and are
mainly the result of neuronal destruction of the gastrointestinal tract (Köberle et
al. 1983).
The pathogenesis of Chagas heart
disease is still not well understood. The host immune response to T. cruzi has
predominantly been studied in experimental infections of mice. In the acute phase, the
neuronal and myocardial lesions are related to the tissue parasitism. The rupture of the
parasite nests results in the release of T. cruzi antigens that sensitize and
transform neurons and muscle fibers (Ribeiro dos Santos & Hudson 1980a, Araujo 1985),
leading to the destruction of these cells by the immune response against the parasite
(Kuhn & Mumane 1977, Ribeiro dos Santos & Hudson 1980b). Recently, in
immunofluorescence studies, we have shown binding of monoclonal antibodies against T.
cruzi in neuronal cell line (Neuro 2A) incubated with T. cruzi extract, (Fig. 1) indicating that different parasite antigens interact with
host cells (manuscript in preparation).
Concerning the chronic phase,
different mechanisms have been proposed. It has been suggested that the lesions result
from a tenacious parasitic invasion. However, the low levels of parasitemia and the very
rare finding of tissue parasites strongly argue against this hypothesis (Köberle 1968).
Second, microvascular abnormalities have been postulated to play a significant role in the
pathogenesis of chronic Chagas heart disease (Rossi et al. 1984, Rossi 1990). Third, the
scarcity of parasites, the polyclonal activation in the acute phase and the presence of
autoreactive antibodies and T cells directed to target organs are evidence that sustain an
autoimmune mechanism in the genesis of chronic disease (Ribeiro dos Santos et al. 1979,
Snary et al. 1983, Kierszenbaum 1985, Minoprio et al. 1986, Minoprio et al. 1988, 1989,
McCormick & Rowland 1989, Bonfá et al. 1993).
We have demonstrated that mice
chronically infected with T. cruzi reject syngeneic heart grafts (Ribeiro dos
Santos et al. 1992). This was in striking contrast to hearts grafted into normal or T. cruzi-immunized
syngeneic recipients, which are not rejected and can persist for more than six months. The
study of heart tissue grafted into chagasic mice revealed a persistent and intense
mononuclear inflammatory infiltrate, quite similar to the pattern obtained in the
allogenic conditions, suggesting that cellular mechanisms are implicated in the rejection.
These studies have also shown that only splenic CD4+ from chronically infected
mice are able to mediate syngeneic heart graft destruction when injected in situ,
whereas CD8+ or non-T cells were not effective. Kinetic studies transferring
CD4+ cells show that the autoreactivity starts 15 days after infection and is
fully established at the 30th day (Ribeiro dos Santos et al. 1991). To further investigate
the phenotype of the cells involved in the phenomenon of syngeneic heart rejection, mice
chronically infected with the Colombian strain of T. cruzi were treated with
anti-CD4 or anti-CD8 monoclonal antibodies (mAb) before the transplantation. The in
vivo depletion of CD4+ cells, but not CD8+ cells, abrogates
rejection Interestingly, when implanted two months after the end of the treatment with
anti-CD4 antibody, the grafts were not rejected despite the fact that CD4+
population was already restored to normal levels. Instead, these grafts persisted for more
than six months, suggesting that the recipients became tolerant, and that this was not a
graft adaptation phenomenon. In contrast, allogeneic grafts were not accepted and were
rejected in 10 to 22 days post-transplantation. The self-reactivity of CD4+ T
cells from chronically infected mice could also be shown in vitro since
lymphocytes from chronic infected mice proliferate in the presence of heart antigens plus
irradiated feeder cells. Non-T cell populations or CD8+ T Iymphocytes failed to
show any activity in this assay. Tolerance after anti-CD4 treatment also correlated with
the disappearance of myocardial reactivities in vitro (Ribeiro dos Santos et
al. 1992).
In order to investigate the state
of tolerance induced by anti-CD4 treatment, we established a model of chronic carditis by
infecting mice with 102 Colombian strain trypomastigotes. After 30 days of
infection, 60 to 70% of the animals survive to the acute phase of the infection, and enter
the chronic phase with low or no parasitemia. Hearts from these animals show multifocal
carditis composed of mononuclear cells and the occasional finding of parasite nests in
myocardial cells. Approximately 40% of the infiltrating cells are T lymphocytes, with a
predominance of the CD4+ phenotype. CD4+ cells were usually spread
throughout the inflammatory foci while CD8+ cells have the tendency to be in
close contact with parasitized myocardial fibers. Chronic chagasic animals were then
submitted to different schedules of monoclonal antibody treatment: (1) anti-CD4;
(2) anti-CD8; (3) anti-Thy1. After five months of follow-up, the animals were
sacrificed. The histopathological and immunocytochemical analysis of the hearts showed
that the chronic carditis was abolished in the animals treated with anti-CD4. The
cumulative mortality is very low in these animals, and parasitemia remains negative during
the whole period of observation. This is in striking contrast with the mortality rates
found with the opposite treatment (anti-CD8 or anti-Thy1), where 90% of the animals die.
The few remaining animals showed an intense carditis, two thirds of the inflammatory T
cells having a CD4+ phenotype with the majority in close contact with
degenerated myocytes (Pirmez & Ribeiro dos Santos 1994).
These results establish that
autoreactivity is restricted to the CD4+ T cell compartment, clearly different
from allogeneic skin graft rejection, which has been attributed to both subsets of T
Iymphocytes (Cobbold et al. 1984, Kitagawa et al. 1990). Altogether, these results are
consistent with the heart graft model and other experimental models of organ-specific
autoimmune diseases in which CD4+ T cells play a major role in the induction of
tissue lesions (Sakaguchi & Sagakuchi 1988, 1989, 1990). This is also in keeping with
data showing that T cells mediating cellular immunity in experimental T. cruzi
infection correspond to CD4+ T cells (Hontebeyrie-Joskowicz et al. 1987, Ben
Younes-Chennoufi et al. 1988). Although some experimental models (Tarleton 1991) as well
as human studies (Molina & Kierszenbaum 1987, Reis et al. 1993, Cunha-Neto 1994) have
shown a predominance of CD8+ cells in heart lesions, it is noteworthy that most
of the T-cell lines or clones reacting against T. cruzi antigens or
self-components such as myosin obtained so far are CD4+ (Britten & Hudson
1985, Dutra et al. 1992, Nickell et al. 1987) and only occasionally CD8+ (Nickell
et al. 1993).
To further study the role of
autoreactivity in the pathogenesis of the myocardium lesions in Chagas' disease, we have
generated a CD4+ T cell line by repeated in vitro antigenic stimulation of
purified splenic CD4+ T lymphocytes from chronically T. cruzi-infected
DBA mice (Colombian strain) (Fig. 2). These T cells proliferate
in the presence of soluble heart antigens and syngeneic feeder cells or in co-cultures
with irradiated splenic syngeneic feeder cells and fetal heart cells. The lymphocytes
originating the cell line appear to have resulted from the in vivo expansion of T.
cruzi-reactive lymphocytes, since the line was activated in vitro by T.
cruzi lysates, in addition to heart antigens. The cell line could also decrease the
number of beating fetal heart cell-clusters in vitro when co-cultured with
irradiated splenic syngeneic feeder cells and fetal heart cells (Fig.
3). In vitro antigen stimulation of the cell line showed a Th1 cytokine
profile, with production of high levels of IFN-g and IL-2 and absence IL-4, IL-5 or IL-10
(Fig. 4). In addition, in situ injection of these cells
into well established heart transplants induce the cessation of heart beating. Adoptive
transfer of the cells to BALB/c nude mice caused 100% mortality of recipients after 1-2
months, compared to controls which received normal CD4+ T cells. Histological
studies revealed the presence of multifocal mononuclear infiltrates in their hearts
similar to those observed during the chronic phase of T. cruzi infection. No
significant alterations were observed in the hearts of BALB/c nude mice transferred with
normal splenic CD4+ T cells. This T cell line also induces destruction of
neuronal cells (in the presence of feeder cells), but only if the target is previously
incubated with parasite antigens (manuscript in preparation).
Recently, we have also obtained
two T cell lines from BALB/c mice infected for one year with the Colombian strain of T.
cruzi. We are currently performing the characterization of the different T cell clones
present in these cell lines and of the antigens recognized by them. This should allow us
to show the existence of cross-reactive T cells against T. cruzi and heart
antigens. Four T cell hybridomas were already obtained by fusion of the first cell line
with BW (thymoma) cell line. From these, two showed reactivity against both T. cruzi and
heart antigens, one reacted only against parasite antigens, and the last showed reactivity
only to heart antigen.
The autoreactivity could be
theoretically elicited by altered self-antigens, formed during heart inflammation, and/or
by T. cruzi antigens cross-reacting with self. In order to identify
cross-reactive antigens, we have generated monoclonal antibodies against T. cruzi.
Four of them (TC1, TC2, TC8, and TC10) are cross-reactive with myocardium, and each
recognises a specific heart and T. cruzi antigen, as shown by western blotting and
by immunofluorescence techniques.
In conclusion, studies in the
murine model of infection with Colombian strain of T. cruzi suggest that the heart
lesions may be caused by two different mechanisms. In the acute phase, parasite antigens
adsorbed or presented in host cell surface are targets for the anti-T. cruzi immune
response, which will lead to destruction of cardiac fibbers and neurones. Lesions are
therefore strongly associated with tissue parasitism. Both CD4+ and CD8+
T cells may play a role in the pathogenic response. Release of self-antigens from damaged
cells may also contribute to the pathology. Second, an autoreactive response against heart
antigens mediated by CD4+ T cells induces injury in the heart. Damage is
dependent on accessory cells such as macrophages, possibly activated by IFN-g and other
cytokines. The heart-specific autoreactive response present during the chronic phase of
the T. cruzi infection may be intensified or even triggered by multiple
parasite-host cell cross-reactivities. As the disease progresses driven by an autoimmune
response, little association between damage and presence of parasites is observed. In both
mechanisms, it is clear that multiple antigens from the parasite as well as self-antigens
are targets for the disease promoting cells.

ACKNOWLEDGMENTS
To Drs José Orivaldo Mengel and
Edilberto Postol for the collaboration in Tcell and monoclonal antibodies techniques.
REFERENCES
Fig.1 | Fig.2 | Fig.3 | Fig.4

+Corresponding author.
Fax: +55-71-356.4292. E-mail: rrsantos@e-net.com.br
Received 9 June 1999
Accepted 9 August 1999